Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Essential Elements of Hazardous Drug Compounding
Tell a Friend About This EventTell a Friend
Essential Elements of Hazardous Drug Compounding

 Export to Your Calendar 11/16/2019 to 11/17/2019
When: Nov 16 - Nov 17, 2019
Where: LP3 Network Facility
21550 Biscayne Blvd, Suite 300
Aventura, Florida  33180
United States
Contact: (844) 408-9453

« Go to Upcoming Event List  



Are you currently compounding with any of these active pharmaceutical ingredients: apomorphone, azathioprin, cyclophosphamide, cyclosporine, diethylstilbestrol, estradiol, fluorouracil, medroxyprogesterone, phenytoin, progesterone, spironolactone, or tacrolimus?


If so, you must be compliant with General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings, which was formally published February 1, 2016 in the First Supplement to USP 39-NF 34. In an effort to provide an adequate timeframe to implement USP <800>, the chapter has a delayed official implementation date of July 1, 20181. While a two-year window may seem to provide sufficient time for preparation, it is important to note that this implementation date is when entities must be compliant; waiting too long to begin the process could negatively impact your practice. It is critical that pharmacies that compound hazardous drugs prepare their equipment, processes, and staff for the requirements of USP <800>. During this training activity, you will learn about personal protective equipment, engineering controls, closed system transfer devices, facility design, workflow considerations, and safe handling practices. Moreover, you will learn how to minimize and prevent hazardous drug contamination and exposure through: powder containment techniques, waste disposal, staff training, and the handling of emergency situations such as chemical spills.


Click here for more information.

Association Management Software Powered by YourMembership  ::  Legal